| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
| 1 | Acute myeloid leukemia 3 genes, 4 drugs (DrugBank) and 43 diseases shown |
1件: KIT |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 2 | Adipocytokine signaling pathway 6 genes, 14 drugs (DrugBank) and 74 diseases shown |
1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 3 | Adrenergic signaling in cardiomyocytes 16 genes, 9 drugs (DrugBank) and 31 diseases shown |
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 2件: AGTR1, AGTR2 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D02716 |
Pregabalin |
5件: 13, 36, 46, 70, 298 |
| 1件: SCN5A |
D01450 |
Bupivacaine |
7件: 46, 53, 70, 96, 168, 226, 298 |
| D07552 |
| D01287 |
Levobupivacaine |
1件: 46 |
| D08116 |
| D00358 |
Lidocaine |
10件: 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
| D02086 |
| D08127 |
| D04048 |
Ropivacaine |
3件: 36, 46, 70 |
| D08490 |
| 4 | African trypanosomiasis 7 genes, 12 drugs (DrugBank) and 45 diseases shown |
1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 4件: IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 5 | AGE-RAGE signaling pathway in diabetic complications 8 genes, 16 drugs (DrugBank) and 56 diseases shown |
1件: AGTR1 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 5件: CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 6 | Alcoholism 7 genes, 3 drugs (DrugBank) and 12 diseases shown |
1件: ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 2件: ADORA2A, ADORA2B |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 7 | Aldosterone synthesis and secretion 7 genes, 5 drugs (DrugBank) and 30 diseases shown |
1件: AGTR1 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 1件: MC2R |
D00146 |
Corticotropin |
12件: 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
| 1件: PDE2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 8 | Aldosterone-regulated sodium reabsorption 4 genes, 1 drug (DrugBank) and 2 diseases shown |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 9 | Allograft rejection 7 genes, 12 drugs (DrugBank) and 46 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| D03222 |
Belatacept |
1件: 46 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 10 | Alzheimer disease 12 genes, 12 drugs (DrugBank) and 73 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 2件: IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 11 | Amoebiasis 10 genes, 14 drugs (DrugBank) and 48 diseases shown |
1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 4件: IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 12 | Amphetamine addiction 10 genes, 3 drugs (DrugBank) and 59 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 13 | AMPK signaling pathway 6 genes, 10 drugs (DrugBank) and 69 diseases shown |
1件: ADRA1A |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| D00359 |
Lovastatin |
10件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 310 |
| D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
| D08492 |
| D00434 |
Simvastatin |
19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 14 | Amyotrophic lateral sclerosis (ALS) 11 genes, 11 drugs (DrugBank) and 69 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 15 | Antifolate resistance 6 genes, 12 drugs (DrugBank) and 55 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 3件: IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 16 | Antigen processing and presentation 2 genes, 9 drugs (DrugBank) and 38 diseases shown |
1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 17 | Apelin signaling pathway 5 genes, 5 drugs (DrugBank) and 55 diseases shown |
1件: AGTR1 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 18 | Apoptosis 2 genes, 9 drugs (DrugBank) and 38 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 19 | Arachidonic acid metabolism 3 genes, 17 drugs (DrugBank) and 23 diseases shown |
3件: PTGES, PTGS1, PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| 2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 5 genes, 2 drugs (DrugBank) and 9 diseases shown |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D02716 |
Pregabalin |
5件: 13, 36, 46, 70, 298 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 21 | Asthma 2 genes, 8 drugs (DrugBank) and 38 diseases shown |
2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 22 | Autoimmune thyroid disease 3 genes, 3 drugs (DrugBank) and 28 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| D03222 |
Belatacept |
1件: 46 |
| 1件: IL10 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 23 | Autophagy - animal 3 genes, 2 drugs (DrugBank) and 46 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 24 | Autophagy - other 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 25 | Axon guidance 6 genes, 3 drugs (DrugBank) and 59 diseases shown |
1件: ABL1 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 26 | B cell receptor signaling pathway 8 genes, 6 drugs (DrugBank) and 56 diseases shown |
1件: BTK |
D10893 |
Acalabrutinib |
1件: 46 |
| D11478 |
Branebrutinib |
1件: 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 27 | Bile secretion 5 genes, 6 drugs (DrugBank) and 36 diseases shown |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| D00359 |
Lovastatin |
10件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 310 |
| D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
| D08492 |
| D00434 |
Simvastatin |
19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 28 | Breast cancer 6 genes, 8 drugs (DrugBank) and 47 diseases shown |
1件: ESR1 |
D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
| 2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
| D01413 |
| D01617 |
| D01953 |
| D04061 |
| D04063 |
| D04064 |
| D04065 |
| D02217 |
Raloxifene |
1件: 46 |
| D08465 |
| 1件: KIT |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PGR |
D00182 |
Norethisterone |
4件: 13, 46, 49, 299 |
| D00953 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 29 | C-type lectin receptor signaling pathway 15 genes, 32 drugs (DrugBank) and 79 diseases shown |
4件: IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 30 | Caffeine metabolism 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
| 31 | Calcium signaling pathway 25 genes, 14 drugs (DrugBank) and 73 diseases shown |
2件: ADORA2A, ADORA2B |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
| 2件: ADORA2A, PDE1B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 6件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: AGTR1 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 1件: CYSLTR1 |
D00529 |
Montelukast |
5件: 13, 46, 85, 98, 228 |
| D08229 |
| 4件: GRIN1, GRIN2A, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: HRH1 |
D00364 |
Loratadine |
3件: 6, 13, 46 |
| 2件: HRH1, PTAFR |
D07407 |
Rupatadine |
1件: 46 |
| 1件: HRH2 |
D00318 |
Famotidine |
3件: 6, 46, 86 |
| 1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: PTGER3 |
D00419 |
Misoprostol |
2件: 46, 271 |
| 32 | cAMP signaling pathway 23 genes, 10 drugs (DrugBank) and 29 diseases shown |
2件: ADORA1, ADORA2A |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
| 8件: ADORA1, ADORA2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 2件: ADRB1, ADRB2 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: MC2R |
D00146 |
Corticotropin |
12件: 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PDE4A |
D00302 |
Dipyridamole |
5件: 46, 49, 51, 66, 224 |
| 4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
| 2件: PTGER2, PTGER3 |
D00419 |
Misoprostol |
2件: 46, 271 |
| 33 | Carbohydrate digestion and absorption 4 genes, 1 drug (DrugBank) and 2 diseases shown |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 34 | Cardiac muscle contraction 8 genes, 2 drugs (DrugBank) and 6 diseases shown |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D02716 |
Pregabalin |
5件: 13, 36, 46, 70, 298 |
| 35 | Cell adhesion molecules (CAMs) 5 genes, 5 drugs (DrugBank) and 31 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| D03222 |
Belatacept |
1件: 46 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
| 36 | Cell cycle 1 gene, 1 drug (DrugBank) and 11 diseases shown |
1件: ABL1 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 37 | Cellular senescence 9 genes, 6 drugs (DrugBank) and 74 diseases shown |
2件: IL1A, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 38 | Central carbon metabolism in cancer 3 genes, 3 drugs (DrugBank) and 41 diseases shown |
1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 2件: KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 39 | cGMP-PKG signaling pathway 26 genes, 11 drugs (DrugBank) and 75 diseases shown |
2件: ADORA1, ADORA3 |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
| 5件: ADORA1, PDE2A, PDE3A, PDE3B, PDE5A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: AGTR1 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 1件: OPRD1 |
D03783 |
Oxycodone |
7件: 6, 13, 46, 70, 226, 231, 298 |
| D05312 |
| D05462 |
| 1件: PDE5A |
D00302 |
Dipyridamole |
5件: 46, 49, 51, 66, 224 |
| D02229 |
Sildenafil |
16件: 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
| D08514 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 40 | Chagas disease (American trypanosomiasis) 13 genes, 17 drugs (DrugBank) and 49 diseases shown |
1件: ACE |
D00621 |
Enalapril |
4件: 19, 46, 66, 113 |
| D07892 |
| D00362 |
Lisinopril |
5件: 46, 66, 67, 113, 222 |
| D08131 |
| D00421 |
Ramipril |
7件: 46, 49, 66, 67, 113, 218, 257 |
| 5件: CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 3件: CD3D, CD3E, CD3G |
D08959 |
Otelixizumab |
1件: 46 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 41 | Chemical carcinogenesis 1 gene, 17 drugs (DrugBank) and 23 diseases shown |
1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 42 | Chemokine signaling pathway 5 genes, 6 drugs (DrugBank) and 20 diseases shown |
1件: CCL2 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: CCR5 |
D06670 |
Maraviroc |
2件: 46, 84 |
| 1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 2件: JAK2, JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 43 | Choline metabolism in cancer 2 genes, 2 drugs (DrugBank) and 39 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 44 | Cholinergic synapse 2 genes, 4 drugs (DrugBank) and 21 diseases shown |
1件: ACHE |
D00670 |
Donepezil |
9件: 5, 6, 13, 46, 78, 124, 127, 156, 206 |
| D07869 |
| 1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 45 | Chronic myeloid leukemia 2 genes, 2 drugs (DrugBank) and 13 diseases shown |
1件: ABL1 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 46 | Circadian entrainment 7 genes, 3 drugs (DrugBank) and 13 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 2件: MTNR1A, MTNR1B |
D08170 |
Melatonin |
8件: 6, 13, 46, 49, 90, 97, 144, 202 |
| D02689 |
Ramelteon |
3件: 6, 8, 46 |
| 47 | Circadian rhythm 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 48 | Cocaine addiction 6 genes, 2 drugs (DrugBank) and 11 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 49 | Collecting duct acid secretion 2 genes, 2 drugs (DrugBank) and 16 diseases shown |
2件: ATP4A, ATP4B |
D01984 |
Esomeprazole |
6件: 6, 46, 86, 98, 298, 299 |
| D04056 |
| D07917 |
| D09339 |
| D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 50 | Colorectal cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 51 | Complement and coagulation cascades 3 genes, 4 drugs (DrugBank) and 7 diseases shown |
1件: F10 |
D09710 |
Edoxaban |
2件: 46, 88 |
| D07086 |
Rivaroxaban |
2件: 46, 49 |
| 1件: PLG |
D01136 |
Tranexamic acid |
5件: 46, 70, 215, 227, 288 |
| 1件: SERPINC1 |
D03674 |
Enoxaparin |
1件: 46 |
| D07510 |
| 52 | Cortisol synthesis and secretion 2 genes, 3 drugs (DrugBank) and 28 diseases shown |
1件: AGTR1 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 1件: MC2R |
D00146 |
Corticotropin |
12件: 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
| 53 | Cushing syndrome 2 genes, 3 drugs (DrugBank) and 28 diseases shown |
1件: AGTR1 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 1件: MC2R |
D00146 |
Corticotropin |
12件: 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
| 54 | Cytokine-cytokine receptor interaction 27 genes, 30 drugs (DrugBank) and 78 diseases shown |
6件: CCL2, IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: CCR5 |
D06670 |
Maraviroc |
2件: 46, 84 |
| 1件: CSF2RA |
D09930 |
Mavrilimumab |
2件: 41, 46 |
| D05712 |
Regramostim |
4件: 11, 46, 51, 229 |
| 1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| 1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 1件: GHR |
D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL17A |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
| 2件: IL17A, IL17F |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
| D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 1件: LTA |
D10187 |
Pateclizumab |
1件: 46 |
| 2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| 1件: LTB |
D08866 |
Baminercept |
4件: 13, 46, 53, 97 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 2件: TNFSF13, TNFSF13B |
D09704 |
Atacicept |
4件: 13, 46, 49, 66 |
| 1件: TNFSF13B |
D03068 |
Belimumab |
8件: 11, 43, 44, 46, 49, 51, 53, 222 |
| D10083 |
Tabalumab |
2件: 46, 49 |
| 55 | Cytosolic DNA-sensing pathway 3 genes, 4 drugs (DrugBank) and 20 diseases shown |
1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 2件: IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 56 | Dilated cardiomyopathy (DCM) 7 genes, 11 drugs (DrugBank) and 48 diseases shown |
1件: ADRB1 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D02716 |
Pregabalin |
5件: 13, 36, 46, 70, 298 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 57 | DNA replication 2 genes, 1 drug (DrugBank) and 9 diseases shown |
2件: POLA1, POLA2 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
| 58 | Dopaminergic synapse 6 genes, 7 drugs (DrugBank) and 65 diseases shown |
2件: GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 3件: PPP3CA, PPP3CB, PPP3CC |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: SCN1A |
D01450 |
Bupivacaine |
7件: 46, 53, 70, 96, 168, 226, 298 |
| D07552 |
| D01287 |
Levobupivacaine |
1件: 46 |
| D08116 |
| D00358 |
Lidocaine |
10件: 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
| D02086 |
| D08127 |
| D04048 |
Ropivacaine |
3件: 36, 46, 70 |
| D08490 |
| 59 | Drug metabolism - other enzymes 4 genes, 4 drugs (DrugBank) and 29 diseases shown |
2件: IMPDH1, IMPDH2 |
D01392 |
Mizoribine |
8件: 46, 49, 51, 53, 66, 94, 222, 224 |
| 1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
| D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
| 60 | ECM-receptor interaction 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 61 | EGFR tyrosine kinase inhibitor resistance 6 genes, 12 drugs (DrugBank) and 57 diseases shown |
1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
| D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 62 | Endocrine and other factor-regulated calcium reabsorption 7 genes, 10 drugs (DrugBank) and 29 diseases shown |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 1件: ESR1 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
| D01413 |
| D01617 |
| D01953 |
| D04061 |
| D04063 |
| D04064 |
| D04065 |
| D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
| D02217 |
Raloxifene |
1件: 46 |
| D08465 |
| 1件: PTH1R |
D06078 |
Teriparatide |
7件: 46, 65, 68, 70, 71, 235, 274 |
| 1件: VDR |
D01518 |
Alfacalcidol |
6件: 41, 46, 49, 50, 96, 235 |
| D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
| D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| D07578 |
Eldecalcitol |
1件: 46 |
| D00187 |
Ergocalciferol |
5件: 46, 84, 96, 97, 299 |
| 63 | Endocrine resistance 3 genes, 4 drugs (DrugBank) and 38 diseases shown |
1件: ESR1 |
D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
| 2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
| D01413 |
| D01617 |
| D01953 |
| D04061 |
| D04063 |
| D04064 |
| D04065 |
| D02217 |
Raloxifene |
1件: 46 |
| D08465 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 64 | Endocytosis 2 genes, 2 drugs (DrugBank) and 12 diseases shown |
1件: CCR5 |
D06670 |
Maraviroc |
2件: 46, 84 |
| 1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 66 | Epstein-Barr virus infection 14 genes, 22 drugs (DrugBank) and 46 diseases shown |
1件: BTK |
D10893 |
Acalabrutinib |
1件: 46 |
| D11478 |
Branebrutinib |
1件: 46 |
| 3件: CD3D, CD3E, CD3G |
D08959 |
Otelixizumab |
1件: 46 |
| 2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| 3件: JAK1, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 67 | ErbB signaling pathway 2 genes, 2 drugs (DrugBank) and 39 diseases shown |
1件: ABL1 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 68 | Estrogen signaling pathway 4 genes, 9 drugs (DrugBank) and 15 diseases shown |
1件: ESR1 |
D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
| 2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
| D01413 |
| D01617 |
| D01953 |
| D04061 |
| D04063 |
| D04064 |
| D04065 |
| D02217 |
Raloxifene |
1件: 46 |
| D08465 |
| 1件: OPRM1 |
D00836 |
Buprenorphine |
2件: 46, 70 |
| D07132 |
| D00320 |
Fentanyl |
5件: 46, 70, 85, 215, 231 |
| D01399 |
| D00842 |
Morphine |
4件: 36, 46, 70, 86 |
| D02271 |
| D08233 |
| D03783 |
Oxycodone |
7件: 6, 13, 46, 70, 226, 231, 298 |
| D05312 |
| D05462 |
| D01355 |
Tramadol |
5件: 46, 70, 78, 226, 271 |
| D08623 |
| 1件: PGR |
D00182 |
Norethisterone |
4件: 13, 46, 49, 299 |
| D00953 |
| 69 | Fc epsilon RI signaling pathway 3 genes, 11 drugs (DrugBank) and 40 diseases shown |
1件: BTK |
D10893 |
Acalabrutinib |
1件: 46 |
| D11478 |
Branebrutinib |
1件: 46 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 70 | Fc gamma R-mediated phagocytosis 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 71 | Fluid shear stress and atherosclerosis 12 genes, 15 drugs (DrugBank) and 60 diseases shown |
4件: CCL2, IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: KEAP1 |
D03846 |
Dimethyl fumarate |
5件: 13, 46, 49, 51, 86 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: NQO1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 72 | Focal adhesion 2 genes, 2 drugs (DrugBank) and 15 diseases shown |
1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 73 | Folate biosynthesis 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 74 | FoxO signaling pathway 4 genes, 3 drugs (DrugBank) and 27 diseases shown |
2件: IL10, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 75 | GABAergic synapse 16 genes, 4 drugs (DrugBank) and 17 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00293 |
Diazepam |
3件: 46, 155, 298 |
| D02624 |
Eszopiclone |
3件: 6, 13, 46 |
| D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 76 | Gap junction 11 genes, 3 drugs (DrugBank) and 17 diseases shown |
1件: ADRB1 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00491 |
Paclitaxel |
2件: 46, 85 |
| D05333 |
| 77 | Gastric acid secretion 7 genes, 4 drugs (DrugBank) and 16 diseases shown |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 2件: ATP4A, ATP4B |
D01984 |
Esomeprazole |
6件: 6, 46, 86, 98, 298, 299 |
| D04056 |
| D07917 |
| D09339 |
| D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 1件: HRH2 |
D00318 |
Famotidine |
3件: 6, 46, 86 |
| 78 | Gastric cancer 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 79 | Glioma 2 genes, 2 drugs (DrugBank) and 39 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 80 | Glucagon signaling pathway 8 genes, 4 drugs (DrugBank) and 65 diseases shown |
1件: PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 81 | Glutamatergic synapse 10 genes, 3 drugs (DrugBank) and 59 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 82 | Glutathione metabolism 1 gene, 2 drugs (DrugBank) and 21 diseases shown |
1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
| D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 83 | Glycerophospholipid metabolism 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ACHE |
D00670 |
Donepezil |
9件: 5, 6, 13, 46, 78, 124, 127, 156, 206 |
| D07869 |
| 84 | GnRH secretion 1 gene, 2 drugs (DrugBank) and 5 diseases shown |
1件: ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
| D01413 |
| D01617 |
| D01953 |
| D04061 |
| D04063 |
| D04064 |
| D04065 |
| D02217 |
Raloxifene |
1件: 46 |
| D08465 |
| 85 | GnRH signaling pathway 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: GNRHR |
D01685 |
Cetrorelix |
1件: 46 |
| D07665 |
| 86 | Graft-versus-host disease 7 genes, 13 drugs (DrugBank) and 50 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| D03222 |
Belatacept |
1件: 46 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 4件: IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 87 | Growth hormone synthesis, secretion and action 3 genes, 5 drugs (DrugBank) and 58 diseases shown |
1件: GHR |
D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 88 | Hematopoietic cell lineage 16 genes, 25 drugs (DrugBank) and 82 diseases shown |
3件: CD3D, CD3E, CD3G |
D08959 |
Otelixizumab |
1件: 46 |
| 1件: CSF2RA |
D09930 |
Mavrilimumab |
2件: 41, 46 |
| D05712 |
Regramostim |
4件: 11, 46, 51, 229 |
| 1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| 1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 4件: IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
| D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 1件: KIT |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 1件: MS4A1 |
D05218 |
Ocrelizumab |
3件: 13, 46, 49 |
| D09314 |
Ofatumumab |
3件: 13, 35, 46 |
| D02994 |
Rituximab |
42件: 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
| D09031 |
Veltuzumab |
1件: 46 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 89 | Hepatitis B 8 genes, 17 drugs (DrugBank) and 42 diseases shown |
1件: IFNAR1 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 3件: JAK1, JAK2, JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| 4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 90 | Hepatitis C 7 genes, 17 drugs (DrugBank) and 42 diseases shown |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10653 |
Peficitinib |
1件: 46 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 91 | Hepatocellular carcinoma 3 genes, 3 drugs (DrugBank) and 40 diseases shown |
1件: KEAP1 |
D03846 |
Dimethyl fumarate |
5件: 13, 46, 49, 51, 86 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NQO1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 92 | Herpes simplex virus 1 infection 16 genes, 23 drugs (DrugBank) and 69 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10653 |
Peficitinib |
1件: 46 |
| 3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: LTA |
D10187 |
Pateclizumab |
1件: 46 |
| 2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 93 | HIF-1 signaling pathway 5 genes, 7 drugs (DrugBank) and 50 diseases shown |
1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
| D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 94 | Human cytomegalovirus infection 20 genes, 43 drugs (DrugBank) and 94 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: CCR5 |
D06670 |
Maraviroc |
2件: 46, 84 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
| D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 3件: PTGER2, PTGER3, PTGER4 |
D00419 |
Misoprostol |
2件: 46, 271 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 95 | Human immunodeficiency virus 1 infection 12 genes, 14 drugs (DrugBank) and 78 diseases shown |
1件: CCR5 |
D06670 |
Maraviroc |
2件: 46, 84 |
| 3件: CD3D, CD3E, CD3G |
D08959 |
Otelixizumab |
1件: 46 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 96 | Human papillomavirus infection 10 genes, 36 drugs (DrugBank) and 75 diseases shown |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10653 |
Peficitinib |
1件: 46 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PTGER4 |
D00419 |
Misoprostol |
2件: 46, 271 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 97 | Human T-cell leukemia virus 1 infection 18 genes, 26 drugs (DrugBank) and 73 diseases shown |
3件: CD3D, CD3E, CD3G |
D08959 |
Otelixizumab |
1件: 46 |
| 1件: FDPS |
D00939 |
Alendronic acid |
7件: 19, 41, 46, 50, 271, 274, 299 |
| D07119 |
| D08056 |
Ibandronate |
2件: 46, 49 |
| D00942 |
Risedronic acid |
7件: 46, 66, 93, 95, 96, 113, 274 |
| D03234 |
| D08484 |
| D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
| D06378 |
| D06379 |
| D08689 |
| 2件: IL1R1, IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: LTA |
D10187 |
Pateclizumab |
1件: 46 |
| 2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 98 | Huntington disease 3 genes, 3 drugs (DrugBank) and 22 diseases shown |
2件: GRIN1, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 99 | Hypertrophic cardiomyopathy (HCM) 10 genes, 15 drugs (DrugBank) and 59 diseases shown |
1件: ACE |
D00621 |
Enalapril |
4件: 19, 46, 66, 113 |
| D07892 |
| D00362 |
Lisinopril |
5件: 46, 66, 67, 113, 222 |
| D08131 |
| D00421 |
Ramipril |
7件: 46, 49, 66, 67, 113, 218, 257 |
| 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D02716 |
Pregabalin |
5件: 13, 36, 46, 70, 298 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 100 | IL-17 signaling pathway 9 genes, 31 drugs (DrugBank) and 57 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 1件: IL17A |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
| 2件: IL17A, IL17F |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 101 | Inflammatory bowel disease (IBD) 12 genes, 15 drugs (DrugBank) and 45 diseases shown |
1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 5件: IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL17A |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
| 2件: IL17A, IL17F |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 102 | Inflammatory mediator regulation of TRP channels 5 genes, 6 drugs (DrugBank) and 29 diseases shown |
1件: HRH1 |
D00364 |
Loratadine |
3件: 6, 13, 46 |
| D07407 |
Rupatadine |
1件: 46 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 2件: PTGER2, PTGER4 |
D00419 |
Misoprostol |
2件: 46, 271 |
| 103 | Influenza A 16 genes, 25 drugs (DrugBank) and 56 diseases shown |
5件: CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: FDPS |
D00939 |
Alendronic acid |
7件: 19, 41, 46, 50, 271, 274, 299 |
| D07119 |
| D08056 |
Ibandronate |
2件: 46, 49 |
| D00942 |
Risedronic acid |
7件: 46, 66, 93, 95, 96, 113, 274 |
| D03234 |
| D08484 |
| D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
| D06378 |
| D06379 |
| D08689 |
| 2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10653 |
Peficitinib |
1件: 46 |
| 3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PLG |
D01136 |
Tranexamic acid |
5件: 46, 70, 215, 227, 288 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 104 | Insulin resistance 6 genes, 12 drugs (DrugBank) and 71 diseases shown |
1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 2件: IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 105 | Insulin secretion 4 genes, 1 drug (DrugBank) and 2 diseases shown |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 106 | Insulin signaling pathway 4 genes, 3 drugs (DrugBank) and 48 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 107 | Intestinal immune network for IgA production 7 genes, 8 drugs (DrugBank) and 33 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| D03222 |
Belatacept |
1件: 46 |
| 2件: IL10, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 2件: TNFSF13, TNFSF13B |
D09704 |
Atacicept |
4件: 13, 46, 49, 66 |
| 1件: TNFSF13B |
D03068 |
Belimumab |
8件: 11, 43, 44, 46, 49, 51, 53, 222 |
| D10083 |
Tabalumab |
2件: 46, 49 |
| 108 | JAK-STAT signaling pathway 19 genes, 20 drugs (DrugBank) and 86 diseases shown |
1件: CSF2RA |
D09930 |
Mavrilimumab |
2件: 41, 46 |
| D05712 |
Regramostim |
4件: 11, 46, 51, 229 |
| 1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| 1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 1件: GHR |
D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 2件: IL10, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
| D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 3件: JAK1, JAK2, JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| 4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 109 | Kaposi sarcoma-associated herpesvirus infection 17 genes, 34 drugs (DrugBank) and 87 diseases shown |
1件: CCR5 |
D06670 |
Maraviroc |
2件: 46, 84 |
| 1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| D03222 |
Belatacept |
1件: 46 |
| 2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10653 |
Peficitinib |
1件: 46 |
| 3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 110 | Legionellosis 6 genes, 12 drugs (DrugBank) and 45 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 3件: IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 111 | Leishmaniasis 12 genes, 36 drugs (DrugBank) and 62 diseases shown |
1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 4件: IL10, IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 112 | Leukocyte transendothelial migration 2 genes, 2 drugs (DrugBank) and 12 diseases shown |
1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 113 | Long-term potentiation 10 genes, 3 drugs (DrugBank) and 59 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 114 | Longevity regulating pathway 5 genes, 5 drugs (DrugBank) and 53 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 115 | Longevity regulating pathway - multiple species 3 genes, 2 drugs (DrugBank) and 46 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 116 | Malaria 8 genes, 13 drugs (DrugBank) and 47 diseases shown |
5件: CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 1件: IL12A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 117 | MAPK signaling pathway 16 genes, 16 drugs (DrugBank) and 74 diseases shown |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D02716 |
Pregabalin |
5件: 13, 36, 46, 70, 298 |
| 3件: IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 2件: KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 118 | Measles 14 genes, 13 drugs (DrugBank) and 31 diseases shown |
3件: CD3D, CD3E, CD3G |
D08959 |
Otelixizumab |
1件: 46 |
| 2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 3件: IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| 3件: JAK1, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 119 | Melanogenesis 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: KIT |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 120 | Melanoma 1 gene, 1 drug (DrugBank) and 11 diseases shown |
1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 121 | Metabolic pathways 25 genes, 39 drugs (DrugBank) and 88 diseases shown |
2件: ATP4A, ATP4B |
D01984 |
Esomeprazole |
6件: 6, 46, 86, 98, 298, 299 |
| D04056 |
| D07917 |
| D09339 |
| D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 1件: DHODH |
D00749 |
Leflunomide |
10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 |
| 1件: FDPS |
D00939 |
Alendronic acid |
7件: 19, 41, 46, 50, 271, 274, 299 |
| D07119 |
| D08056 |
Ibandronate |
2件: 46, 49 |
| D00942 |
Risedronic acid |
7件: 46, 66, 93, 95, 96, 113, 274 |
| D03234 |
| D08484 |
| D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
| D06378 |
| D06379 |
| D08689 |
| 1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| D00359 |
Lovastatin |
10件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 310 |
| D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
| D08492 |
| D00434 |
Simvastatin |
19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 2件: IMPDH1, IMPDH2 |
D01392 |
Mizoribine |
8件: 46, 49, 51, 53, 66, 94, 222, 224 |
| 2件: NQO1, VKORC1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 9件: PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
| 2件: PDE4A, PDE5A |
D00302 |
Dipyridamole |
5件: 46, 49, 51, 66, 224 |
| 1件: PDE5A |
D02229 |
Sildenafil |
16件: 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
| D08514 |
| 3件: PTGES, PTGS1, PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| 2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
| D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
| 122 | MicroRNAs in cancer 5 genes, 20 drugs (DrugBank) and 50 diseases shown |
2件: ABL1, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 123 | Mineral absorption 5 genes, 6 drugs (DrugBank) and 24 diseases shown |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 1件: VDR |
D01518 |
Alfacalcidol |
6件: 41, 46, 49, 50, 96, 235 |
| D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
| D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| D07578 |
Eldecalcitol |
1件: 46 |
| D00187 |
Ergocalciferol |
5件: 46, 84, 96, 97, 299 |
| 124 | Morphine addiction 26 genes, 13 drugs (DrugBank) and 33 diseases shown |
1件: ADORA1 |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
| 9件: ADORA1, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00293 |
Diazepam |
3件: 46, 155, 298 |
| D02624 |
Eszopiclone |
3件: 6, 13, 46 |
| D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 1件: OPRM1 |
D00836 |
Buprenorphine |
2件: 46, 70 |
| D07132 |
| D00320 |
Fentanyl |
5件: 46, 70, 85, 215, 231 |
| D01399 |
| D00842 |
Morphine |
4件: 36, 46, 70, 86 |
| D02271 |
| D08233 |
| D03783 |
Oxycodone |
7件: 6, 13, 46, 70, 226, 231, 298 |
| D05312 |
| D05462 |
| D01355 |
Tramadol |
5件: 46, 70, 78, 226, 271 |
| D08623 |
| 1件: PDE4A |
D00302 |
Dipyridamole |
5件: 46, 49, 51, 66, 224 |
| 4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
| 125 | mTOR signaling pathway 4 genes, 10 drugs (DrugBank) and 71 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 126 | Natural killer cell mediated cytotoxicity 11 genes, 14 drugs (DrugBank) and 65 diseases shown |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 127 | Necroptosis 10 genes, 17 drugs (DrugBank) and 46 diseases shown |
2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 3件: IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 3件: JAK1, JAK2, JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| 4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 128 | Neuroactive ligand-receptor interaction 56 genes, 35 drugs (DrugBank) and 100 diseases shown |
2件: ADORA1, ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
| 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 2件: AGTR1, AGTR2 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| 2件: CNR1, CNR2 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| D00306 |
Dronabinol |
5件: 2, 13, 46, 271, 298 |
| 1件: CYSLTR1 |
D00529 |
Montelukast |
5件: 13, 46, 85, 98, 228 |
| D08229 |
| 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00293 |
Diazepam |
3件: 46, 155, 298 |
| D02624 |
Eszopiclone |
3件: 6, 13, 46 |
| D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 1件: GHR |
D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 1件: GNRHR |
D01685 |
Cetrorelix |
1件: 46 |
| D07665 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: HRH1 |
D00364 |
Loratadine |
3件: 6, 13, 46 |
| 2件: HRH1, PTAFR |
D07407 |
Rupatadine |
1件: 46 |
| 1件: HRH2 |
D00318 |
Famotidine |
3件: 6, 46, 86 |
| 1件: MC2R |
D00146 |
Corticotropin |
12件: 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
| 2件: MTNR1A, MTNR1B |
D08170 |
Melatonin |
8件: 6, 13, 46, 49, 90, 97, 144, 202 |
| D02689 |
Ramelteon |
3件: 6, 8, 46 |
| 1件: NR3C1 |
D00244 |
Betamethasone |
6件: 2, 46, 65, 90, 96, 235 |
| D00972 |
| D01357 |
| D01402 |
| D01637 |
| D02032 |
| D02286 |
| D00292 |
Dexamethasone |
20件: 13, 16, 28, 35, 46, 53, 63, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 222, 296, 299 |
| D00975 |
| D01510 |
| D01615 |
| D01632 |
| D01948 |
| D02174 |
| D02591 |
| D02592 |
| D00407 |
Methylprednisolone |
36件: 2, 13, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 145, 164, 220, 222, 224, 271, 283, 284, 285, 296 |
| D00751 |
| D00979 |
| D05000 |
| D05001 |
| D05002 |
| D00472 |
Prednisolone |
38件: 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
| D00980 |
| D00981 |
| D00982 |
| D01239 |
| D01998 |
| D02156 |
| D03301 |
| D00473 |
Prednisone |
44件: 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
| D00385 |
Triamcinolone |
18件: 6, 10, 13, 35, 40, 41, 42, 43, 44, 45, 46, 56, 70, 90, 96, 97, 226, 298 |
| D00983 |
| D00984 |
| D00985 |
| D06216 |
| 3件: OPRD1, OPRK1, OPRM1 |
D03783 |
Oxycodone |
7件: 6, 13, 46, 70, 226, 231, 298 |
| D05312 |
| D05462 |
| 2件: OPRK1, OPRM1 |
D00836 |
Buprenorphine |
2件: 46, 70 |
| D07132 |
| 1件: OPRM1 |
D00320 |
Fentanyl |
5件: 46, 70, 85, 215, 231 |
| D01399 |
| D00842 |
Morphine |
4件: 36, 46, 70, 86 |
| D02271 |
| D08233 |
| D01355 |
Tramadol |
5件: 46, 70, 78, 226, 271 |
| D08623 |
| 1件: PLG |
D01136 |
Tranexamic acid |
5件: 46, 70, 215, 227, 288 |
| 3件: PTGER2, PTGER3, PTGER4 |
D00419 |
Misoprostol |
2件: 46, 271 |
| 1件: PTH1R |
D06078 |
Teriparatide |
7件: 46, 65, 68, 70, 71, 235, 274 |
| 129 | Neurotrophin signaling pathway 2 genes, 2 drugs (DrugBank) and 13 diseases shown |
1件: ABL1 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 130 | NF-kappa B signaling pathway 11 genes, 37 drugs (DrugBank) and 63 diseases shown |
1件: BTK |
D10893 |
Acalabrutinib |
1件: 46 |
| D11478 |
Branebrutinib |
1件: 46 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 2件: IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: LTA |
D10187 |
Pateclizumab |
1件: 46 |
| 2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| 1件: LTB |
D08866 |
Baminercept |
4件: 13, 46, 53, 97 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 1件: TNFSF13B |
D09704 |
Atacicept |
4件: 13, 46, 49, 66 |
| D03068 |
Belimumab |
8件: 11, 43, 44, 46, 49, 51, 53, 222 |
| D10083 |
Tabalumab |
2件: 46, 49 |
| 131 | Nicotine addiction 21 genes, 5 drugs (DrugBank) and 20 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00293 |
Diazepam |
3件: 46, 155, 298 |
| D02624 |
Eszopiclone |
3件: 6, 13, 46 |
| D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 132 | NOD-like receptor signaling pathway 9 genes, 18 drugs (DrugBank) and 46 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10653 |
Peficitinib |
1件: 46 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 133 | Non-alcoholic fatty liver disease (NAFLD) 8 genes, 14 drugs (DrugBank) and 60 diseases shown |
4件: IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
| D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 134 | Non-small cell lung cancer 1 gene, 2 drugs (DrugBank) and 9 diseases shown |
1件: JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 135 | Olfactory transduction 2 genes, 1 drug (DrugBank) and 6 diseases shown |
2件: PDE1B, PDE2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 136 | One carbon pool by folate 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 137 | Oocyte meiosis 6 genes, 3 drugs (DrugBank) and 55 diseases shown |
1件: PGR |
D00182 |
Norethisterone |
4件: 13, 46, 49, 299 |
| D00953 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 138 | Osteoclast differentiation 19 genes, 27 drugs (DrugBank) and 78 diseases shown |
1件: BTK |
D10893 |
Acalabrutinib |
1件: 46 |
| D11478 |
Branebrutinib |
1件: 46 |
| 2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 3件: IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10653 |
Peficitinib |
1件: 46 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 139 | Ovarian steroidogenesis 1 gene, 17 drugs (DrugBank) and 23 diseases shown |
1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 140 | Oxidative phosphorylation 2 genes, 2 drugs (DrugBank) and 16 diseases shown |
2件: ATP4A, ATP4B |
D01984 |
Esomeprazole |
6件: 6, 46, 86, 98, 298, 299 |
| D04056 |
| D07917 |
| D09339 |
| D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 141 | Oxytocin signaling pathway 12 genes, 21 drugs (DrugBank) and 76 diseases shown |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 |
D02716 |
Pregabalin |
5件: 13, 36, 46, 70, 298 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 142 | Pancreatic cancer 3 genes, 8 drugs (DrugBank) and 47 diseases shown |
1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 143 | Pancreatic secretion 4 genes, 1 drug (DrugBank) and 2 diseases shown |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 144 | Parathyroid hormone synthesis, secretion and action 7 genes, 10 drugs (DrugBank) and 35 diseases shown |
1件: PDE4A |
D00302 |
Dipyridamole |
5件: 46, 49, 51, 66, 224 |
| 4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
| D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 1件: PTH1R |
D06078 |
Teriparatide |
7件: 46, 65, 68, 70, 71, 235, 274 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 1件: VDR |
D01518 |
Alfacalcidol |
6件: 41, 46, 49, 50, 96, 235 |
| D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
| D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| D07578 |
Eldecalcitol |
1件: 46 |
| D00187 |
Ergocalciferol |
5件: 46, 84, 96, 97, 299 |
| 145 | Parkinson disease 1 gene, 2 drugs (DrugBank) and 10 diseases shown |
1件: ADORA2A |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
| D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 146 | Pathogenic Escherichia coli infection 15 genes, 14 drugs (DrugBank) and 49 diseases shown |
1件: ABL1 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 3件: IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00491 |
Paclitaxel |
2件: 46, 85 |
| D05333 |
| 147 | Pathways in cancer 29 genes, 48 drugs (DrugBank) and 93 diseases shown |
3件: ABL1, KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 1件: AGTR1 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 1件: CSF2RA |
D09930 |
Mavrilimumab |
2件: 41, 46 |
| D05712 |
Regramostim |
4件: 11, 46, 51, 229 |
| 1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| 1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 1件: ESR1 |
D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
| 2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
| D01413 |
| D01617 |
| D01953 |
| D04061 |
| D04063 |
| D04064 |
| D04065 |
| D02217 |
Raloxifene |
1件: 46 |
| D08465 |
| 2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
| D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 3件: JAK1, JAK2, JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: KEAP1 |
D03846 |
Dimethyl fumarate |
5件: 13, 46, 49, 51, 86 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: NQO1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 3件: PTGER2, PTGER3, PTGER4 |
D00419 |
Misoprostol |
2件: 46, 271 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 148 | PD-L1 expression and PD-1 checkpoint pathway in cancer 14 genes, 13 drugs (DrugBank) and 78 diseases shown |
3件: CD3D, CD3E, CD3G |
D08959 |
Otelixizumab |
1件: 46 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 149 | Peroxisome 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
| 150 | Pertussis 9 genes, 12 drugs (DrugBank) and 45 diseases shown |
5件: IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 151 | Phagosome 9 genes, 1 drug (DrugBank) and 2 diseases shown |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D00491 |
Paclitaxel |
2件: 46, 85 |
| D05333 |
| 152 | Phospholipase D signaling pathway 5 genes, 6 drugs (DrugBank) and 51 diseases shown |
1件: AGTR1 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 2件: KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 153 | PI3K-Akt signaling pathway 18 genes, 21 drugs (DrugBank) and 87 diseases shown |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| 1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 1件: GHR |
D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
| D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 3件: JAK1, JAK2, JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 2件: KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 154 | Platelet activation 4 genes, 13 drugs (DrugBank) and 20 diseases shown |
1件: BTK |
D10893 |
Acalabrutinib |
1件: 46 |
| D11478 |
Branebrutinib |
1件: 46 |
| 1件: P2RY12 |
D09017 |
Ticagrelor |
1件: 46 |
| 1件: PTGS1 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 155 | PPAR signaling pathway 1 gene, 2 drugs (DrugBank) and 20 diseases shown |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 156 | Primary immunodeficiency 4 genes, 5 drugs (DrugBank) and 9 diseases shown |
1件: BTK |
D10893 |
Acalabrutinib |
1件: 46 |
| D11478 |
Branebrutinib |
1件: 46 |
| 2件: CD3D, CD3E |
D08959 |
Otelixizumab |
1件: 46 |
| 1件: JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 157 | Prion diseases 3 genes, 3 drugs (DrugBank) and 18 diseases shown |
3件: IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 158 | Progesterone-mediated oocyte maturation 2 genes, 2 drugs (DrugBank) and 9 diseases shown |
1件: PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 1件: PGR |
D00182 |
Norethisterone |
4件: 13, 46, 49, 299 |
| D00953 |
| 159 | Prolactin signaling pathway 5 genes, 8 drugs (DrugBank) and 19 diseases shown |
1件: ESR1 |
D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
| 2件: ESR1, ESR2 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
| D01413 |
| D01617 |
| D01953 |
| D04061 |
| D04063 |
| D04064 |
| D04065 |
| D02217 |
Raloxifene |
1件: 46 |
| D08465 |
| 1件: JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 160 | Prostate cancer 4 genes, 4 drugs (DrugBank) and 51 diseases shown |
1件: IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 161 | Proteasome 2 genes, 2 drugs (DrugBank) and 13 diseases shown |
1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 1件: PSMB5 |
D03150 |
Bortezomib |
13件: 11, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 288, 331 |
| 162 | Protein digestion and absorption 4 genes, 1 drug (DrugBank) and 2 diseases shown |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 163 | Proteoglycans in cancer 4 genes, 13 drugs (DrugBank) and 63 diseases shown |
1件: ESR1 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
| D01413 |
| D01617 |
| D01953 |
| D04061 |
| D04063 |
| D04064 |
| D04065 |
| D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
| D02217 |
Raloxifene |
1件: 46 |
| D08465 |
| 1件: IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 164 | Proximal tubule bicarbonate reclamation 4 genes, 1 drug (DrugBank) and 2 diseases shown |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 165 | Purine metabolism 13 genes, 8 drugs (DrugBank) and 44 diseases shown |
2件: IMPDH1, IMPDH2 |
D01392 |
Mizoribine |
8件: 46, 49, 51, 53, 66, 94, 222, 224 |
| 9件: PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
| 2件: PDE4A, PDE5A |
D00302 |
Dipyridamole |
5件: 46, 49, 51, 66, 224 |
| 1件: PDE5A |
D02229 |
Sildenafil |
16件: 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
| D08514 |
| 1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
| D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
| 166 | Pyrimidine metabolism 2 genes, 3 drugs (DrugBank) and 28 diseases shown |
1件: DHODH |
D00749 |
Leflunomide |
10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 |
| 1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
| D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 167 | Rap1 signaling pathway 9 genes, 8 drugs (DrugBank) and 35 diseases shown |
1件: ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 2件: ADORA2A, ADORA2B |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
| 1件: CNR1 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| D00306 |
Dronabinol |
5件: 2, 13, 46, 271, 298 |
| 3件: GRIN1, GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 2件: KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 168 | Ras signaling pathway 7 genes, 4 drugs (DrugBank) and 21 diseases shown |
3件: ABL1, KIT, PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 3件: GRIN1, GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 169 | Regulation of actin cytoskeleton 3 genes, 3 drugs (DrugBank) and 21 diseases shown |
1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: PDGFRA |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 170 | Regulation of lipolysis in adipocytes 8 genes, 21 drugs (DrugBank) and 29 diseases shown |
1件: ADORA1 |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
| 2件: ADORA1, PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 3件: ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: PTGER3 |
D00419 |
Misoprostol |
2件: 46, 271 |
| 2件: PTGS1, PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 171 | Relaxin signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 172 | Renin secretion 16 genes, 11 drugs (DrugBank) and 69 diseases shown |
1件: ACE |
D00621 |
Enalapril |
4件: 19, 46, 66, 113 |
| D07892 |
| D00362 |
Lisinopril |
5件: 46, 66, 67, 113, 222 |
| D08131 |
| D00421 |
Ramipril |
7件: 46, 49, 66, 67, 113, 218, 257 |
| 1件: ADORA1 |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
| 4件: ADORA1, PDE1B, PDE3A, PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 3件: ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: AGTR1 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 2件: PTGER2, PTGER4 |
D00419 |
Misoprostol |
2件: 46, 271 |
| 173 | Renin-angiotensin system 3 genes, 5 drugs (DrugBank) and 23 diseases shown |
1件: ACE |
D00621 |
Enalapril |
4件: 19, 46, 66, 113 |
| D07892 |
| D00362 |
Lisinopril |
5件: 46, 66, 67, 113, 222 |
| D08131 |
| D00421 |
Ramipril |
7件: 46, 49, 66, 67, 113, 218, 257 |
| 1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 2件: AGTR1, AGTR2 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| 174 | Retrograde endocannabinoid signaling 18 genes, 23 drugs (DrugBank) and 35 diseases shown |
1件: CNR1 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| D00306 |
Dronabinol |
5件: 2, 13, 46, 271, 298 |
| 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00293 |
Diazepam |
3件: 46, 155, 298 |
| D02624 |
Eszopiclone |
3件: 6, 13, 46 |
| D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 175 | Rheumatoid arthritis 15 genes, 22 drugs (DrugBank) and 54 diseases shown |
5件: CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| D03222 |
Belatacept |
1件: 46 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 1件: IL17A |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
| D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: LTB |
D08866 |
Baminercept |
4件: 13, 46, 53, 97 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 2件: TNFSF13, TNFSF13B |
D09704 |
Atacicept |
4件: 13, 46, 49, 66 |
| 1件: TNFSF13B |
D03068 |
Belimumab |
8件: 11, 43, 44, 46, 49, 51, 53, 222 |
| D10083 |
Tabalumab |
2件: 46, 49 |
| 176 | RIG-I-like receptor signaling pathway 4 genes, 10 drugs (DrugBank) and 40 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 177 | Salivary secretion 10 genes, 2 drugs (DrugBank) and 10 diseases shown |
6件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 178 | Salmonella infection 5 genes, 5 drugs (DrugBank) and 20 diseases shown |
1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 3件: IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 179 | Serotonergic synapse 6 genes, 26 drugs (DrugBank) and 31 diseases shown |
3件: GABRB1, GABRB2, GABRB3 |
D00293 |
Diazepam |
3件: 46, 155, 298 |
| D02624 |
Eszopiclone |
3件: 6, 13, 46 |
| D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 2件: PTGS1, PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 1件: SLC6A4 |
D00228 |
Amoxapine |
1件: 46 |
| D00822 |
Citalopram |
3件: 8, 46, 127 |
| D07704 |
| D08222 |
Milnacipran |
2件: 46, 49 |
| D02260 |
Paroxetine |
3件: 6, 13, 46 |
| D02362 |
| D05374 |
| D05375 |
| D00821 |
Venlafaxine |
3件: 6, 13, 46 |
| D08670 |
| 180 | Shigellosis 6 genes, 13 drugs (DrugBank) and 68 diseases shown |
1件: ABL1 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 2件: IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 181 | Signaling pathways regulating pluripotency of stem cells 3 genes, 6 drugs (DrugBank) and 17 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 3件: JAK1, JAK2, JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 182 | Small cell lung cancer 2 genes, 18 drugs (DrugBank) and 24 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 183 | Sphingolipid signaling pathway 5 genes, 12 drugs (DrugBank) and 44 diseases shown |
1件: ADORA1 |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 2件: ADORA1, ADORA3 |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: OPRD1 |
D03783 |
Oxycodone |
7件: 6, 13, 46, 70, 226, 231, 298 |
| D05312 |
| D05462 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 184 | Staphylococcus aureus infection 4 genes, 4 drugs (DrugBank) and 22 diseases shown |
1件: IL10 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: PLG |
D01136 |
Tranexamic acid |
5件: 46, 70, 215, 227, 288 |
| 1件: PTAFR |
D07407 |
Rupatadine |
1件: 46 |
| 185 | Synaptic vesicle cycle 2 genes, 5 drugs (DrugBank) and 6 diseases shown |
2件: SLC6A2, SLC6A4 |
D00228 |
Amoxapine |
1件: 46 |
| D08222 |
Milnacipran |
2件: 46, 49 |
| D00821 |
Venlafaxine |
3件: 6, 13, 46 |
| D08670 |
| 1件: SLC6A4 |
D00822 |
Citalopram |
3件: 8, 46, 127 |
| D07704 |
| D02260 |
Paroxetine |
3件: 6, 13, 46 |
| D02362 |
| D05374 |
| D05375 |
| 186 | Systemic lupus erythematosus 7 genes, 12 drugs (DrugBank) and 51 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| D03222 |
Belatacept |
1件: 46 |
| 2件: GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 187 | T cell receptor signaling pathway 13 genes, 14 drugs (DrugBank) and 65 diseases shown |
3件: CD3D, CD3E, CD3G |
D08959 |
Otelixizumab |
1件: 46 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 188 | Taste transduction 10 genes, 10 drugs (DrugBank) and 25 diseases shown |
6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D00293 |
Diazepam |
3件: 46, 155, 298 |
| D02624 |
Eszopiclone |
3件: 6, 13, 46 |
| D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| D00549 |
Propofol |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
| 1件: PDE1B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 3件: SCN2A, SCN3A, SCN9A |
D01450 |
Bupivacaine |
7件: 46, 53, 70, 96, 168, 226, 298 |
| D07552 |
| D01287 |
Levobupivacaine |
1件: 46 |
| D08116 |
| D00358 |
Lidocaine |
10件: 6, 13, 46, 84, 86, 97, 168, 226, 231, 256 |
| D02086 |
| D08127 |
| D04048 |
Ropivacaine |
3件: 36, 46, 70 |
| D08490 |
| 2件: SCN3A, SCN9A |
D07299 |
Lacosamide |
3件: 2, 46, 149 |
| 189 | Terpenoid backbone biosynthesis 2 genes, 9 drugs (DrugBank) and 42 diseases shown |
1件: FDPS |
D00939 |
Alendronic acid |
7件: 19, 41, 46, 50, 271, 274, 299 |
| D07119 |
| D08056 |
Ibandronate |
2件: 46, 49 |
| D00942 |
Risedronic acid |
7件: 46, 66, 93, 95, 96, 113, 274 |
| D03234 |
| D08484 |
| D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
| D06378 |
| D06379 |
| D08689 |
| 1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| D00359 |
Lovastatin |
10件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 310 |
| D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
| D08492 |
| D00434 |
Simvastatin |
19件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 162, 195, 265, 298, 299, 310 |
| 190 | TGF-beta signaling pathway 2 genes, 9 drugs (DrugBank) and 38 diseases shown |
1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 191 | Th1 and Th2 cell differentiation 16 genes, 12 drugs (DrugBank) and 62 diseases shown |
3件: CD3D, CD3E, CD3G |
D08959 |
Otelixizumab |
1件: 46 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 3件: JAK1, JAK2, JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| 4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 192 | Th17 cell differentiation 22 genes, 21 drugs (DrugBank) and 85 diseases shown |
3件: CD3D, CD3E, CD3G |
D08959 |
Otelixizumab |
1件: 46 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 1件: IL17A |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
| 2件: IL17A, IL17F |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 2件: IL1B, IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1R1 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
| D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| 3件: JAK1, JAK2, JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| 4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 193 | Thermogenesis 6 genes, 7 drugs (DrugBank) and 60 diseases shown |
1件: ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: CNR1 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| D00306 |
Dronabinol |
5件: 2, 13, 46, 271, 298 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 194 | Thyroid cancer 1 gene, 2 drugs (DrugBank) and 20 diseases shown |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 195 | Thyroid hormone signaling pathway 6 genes, 5 drugs (DrugBank) and 39 diseases shown |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 1件: ESR1 |
D00105 |
Estradiol |
5件: 13, 46, 49, 226, 299 |
| D01413 |
| D01617 |
| D01953 |
| D04061 |
| D04063 |
| D04064 |
| D04065 |
| D00554 |
Ethinylestradiol |
4件: 13, 46, 49, 299 |
| D02217 |
Raloxifene |
1件: 46 |
| D08465 |
| 1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 196 | Thyroid hormone synthesis 4 genes, 1 drug (DrugBank) and 2 diseases shown |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 |
D00298 |
Digoxin |
2件: 8, 46 |
| 197 | Tight junction 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 198 | TNF signaling pathway 7 genes, 29 drugs (DrugBank) and 57 diseases shown |
4件: CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: LTA |
D10187 |
Pateclizumab |
1件: 46 |
| 2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 199 | Toll-like receptor signaling pathway 10 genes, 15 drugs (DrugBank) and 50 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| D03222 |
Belatacept |
1件: 46 |
| 2件: IFNAR1, IFNAR2 |
D11082 |
Anifrolumab |
2件: 46, 49 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 3件: IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 200 | Toxoplasmosis 10 genes, 18 drugs (DrugBank) and 43 diseases shown |
1件: CCR5 |
D06670 |
Maraviroc |
2件: 46, 84 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 2件: IL10, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10653 |
Peficitinib |
1件: 46 |
| 3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 201 | Transcriptional misregulation in cancer 5 genes, 8 drugs (DrugBank) and 45 diseases shown |
1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| D03222 |
Belatacept |
1件: 46 |
| 1件: IL1R2 |
D02934 |
Anakinra |
17件: 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 1件: IL6 |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| D00596 |
Rosiglitazone |
5件: 46, 75, 97, 222, 265 |
| D08491 |
| 202 | Tuberculosis 19 genes, 27 drugs (DrugBank) and 74 diseases shown |
1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 5件: IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 1件: VDR |
D01518 |
Alfacalcidol |
6件: 41, 46, 49, 50, 96, 235 |
| D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
| D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| D07578 |
Eldecalcitol |
1件: 46 |
| D00187 |
Ergocalciferol |
5件: 46, 84, 96, 97, 299 |
| 203 | Type I diabetes mellitus 9 genes, 14 drugs (DrugBank) and 50 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| D03222 |
Belatacept |
1件: 46 |
| 1件: IFNG |
D04242 |
Fontolizumab |
1件: 46 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 3件: IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: LTA |
D10187 |
Pateclizumab |
1件: 46 |
| 2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 204 | Type II diabetes mellitus 2 genes, 9 drugs (DrugBank) and 61 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 205 | Ubiquinone and other terpenoid-quinone biosynthesis 2 genes, 1 drug (DrugBank) and 10 diseases shown |
2件: NQO1, VKORC1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 206 | Ubiquitin mediated proteolysis 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: KEAP1 |
D03846 |
Dimethyl fumarate |
5件: 13, 46, 49, 51, 86 |
| 207 | Vascular smooth muscle contraction 6 genes, 5 drugs (DrugBank) and 29 diseases shown |
1件: ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 2件: ADORA2A, ADORA2B |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
| 3件: ADRA1A, ADRA1B, ADRA1D |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: AGTR1 |
D00150 |
Angiotensin II |
7件: 17, 19, 46, 66, 86, 222, 224 |
| D02014 |
| D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 208 | VEGF signaling pathway 6 genes, 19 drugs (DrugBank) and 67 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: PTGS2 |
D01545 |
Aceclofenac |
1件: 46 |
| D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
| D00109 |
Acetylsalicylic acid |
10件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
| D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
| D00904 |
| D07816 |
| D00315 |
Etodolac |
1件: 46 |
| D03710 |
Etoricoxib |
2件: 46, 271 |
| D00330 |
Flurbiprofen |
2件: 13, 46 |
| D01475 |
| D02290 |
| D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
| D01122 |
| D04490 |
| D06606 |
| D00132 |
Ketoprofen |
1件: 46 |
| D08149 |
Loxoprofen |
2件: 46, 271 |
| D03714 |
Lumiracoxib |
1件: 46 |
| D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
| D00118 |
Naproxen |
3件: 13, 46, 271 |
| D01049 |
Nimesulide |
1件: 46 |
| D03716 |
Parecoxib |
2件: 46, 271 |
| D02709 |
Valdecoxib |
1件: 46 |
| 209 | Viral carcinogenesis 5 genes, 9 drugs (DrugBank) and 19 diseases shown |
1件: CCR5 |
D06670 |
Maraviroc |
2件: 46, 84 |
| 1件: JAK1 |
D10308 |
Baricitinib |
8件: 41, 46, 49, 50, 93, 107, 265, 325 |
| D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10944 |
Itacitinib |
4件: 46, 60, 97, 228 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK3 |
D10653 |
Peficitinib |
1件: 46 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
| 210 | Viral myocarditis 4 genes, 4 drugs (DrugBank) and 35 diseases shown |
1件: ABL1 |
D01441 |
Imatinib |
11件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 89, 162 |
| D08066 |
| 2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| D03222 |
Belatacept |
1件: 46 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 211 | Viral protein interaction with cytokine and cytokine receptor 7 genes, 13 drugs (DrugBank) and 46 diseases shown |
4件: CCL2, IL10, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: CCR5 |
D06670 |
Maraviroc |
2件: 46, 84 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
| D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
| 1件: LTA |
D10187 |
Pateclizumab |
1件: 46 |
| 2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |
| 212 | Wnt signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 213 | Yersinia infection 7 genes, 12 drugs (DrugBank) and 46 diseases shown |
5件: CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 1件: IL1B |
D09315 |
Canakinumab |
9件: 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 1件: IL6 |
D10080 |
Sirukumab |
2件: 41, 46 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D09944 |
Ozoralizumab |
1件: 46 |
| D05393 |
Pegsunercept |
1件: 46 |